| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 332 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 324 |
| 2 | TACROLIMUS OINTMENT 0.1% | 324 |
| 3 | PREDNISONE | 229 |
| 4 | MYCOPHENOLATE MOFETIL | 228 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 228 |
| 6 | PREDNISOLONE | 129 |
| 7 | PREDNISOLONE ORAL | 129 |
| 8 | PREDNISOLONE ORAL SOLUTION | 129 |
| 9 | METHYLPREDNISOLONE | 77 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALITRETINOIN | 2 | 0.0168 |
| 1 | BASILIXIMAB | 60 | 0.0050 |
| 2 | BELATACEPT | 17 | 0.0036 |
| 3 | GANCICLOVIR SODIUM | 37 | 0.0035 |
| 4 | PANTHENOL | 1 | 0.0034 |
| 5 | MARIBAVIR | 8 | 0.0032 |
| 6 | SIROLIMUS | 43 | 0.0031 |
| 7 | CARMUSTINE | 14 | 0.0030 |
| 8 | TACROLIMUS OINTMENT 0.1% | 324 | 0.0025 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 324 | 0.0025 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Selective T Cell Costimulation Blocker [EPC] | 17 | 0.0036 |
| 1 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 8 | 0.0032 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 59 | 0.0026 |
| 3 | Antimalarial [EPC] | 11 | 0.0011 |
| 4 | Antiprotozoal [EPC] | 11 | 0.0010 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 22 | 0.0010 |
| 6 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 8 | 0.0006 |
| 7 | Purine Antimetabolite [EPC] | 52 | 0.0005 |
| 8 | Nucleoside Analog Antiviral [EPC] | 41 | 0.0005 |
| 9 | Lipid-based Polyene Antifungal [EPC] | 6 | 0.0005 |